Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

Go back to Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

Anebulo Pharmaceuticals, Inc. (ANEB) Tops Q1 EPS by 7c

November 13, 2025 4:08 PM EST

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q1 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

... More